Related Experiment Video
Updated: Jun 9, 2025

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor
Cuiling Zhang1, Qiwei Jiang1, Zirui Liu1
1Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.
Abstract:
Autophagy is a cellular self-defense mechanism by which cells can kill invading pathogenic microorganisms and increase the presentation of components of pathogens as antigens. Contrarily, pathogens can utilize autophagy to enhance their own replication. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) NSP6 can interact with ATPase proton pump component to inhibit lysosomal acidification, which was implicated in the autophagy process. However, research on how SARS-CoV-2 NSP6 affected autophagy, and its impact on virus replication is still lacking. Coronavirus NSP6 has been reported to promote coronavirus replication by limiting autophagosome expansion. However, this finding has not been confirmed in coronavirus disease 2019 (COVID-19). We investigated the effect of NSP6 protein on autophagosomes in different mutant strains of SARS-CoV-2 and revealed that the size of autophagosomes was reduced by NSP6 of the wild-type and Delta variant of SARS-CoV-2. In addition, we found that SARS-CoV-2 NSP6 localized to the lysosome and had an inhibitory effect on the binding of autophagosomes to the lysosome, which blocked the autophagy flux; this may be related to endoplasmic reticulum (ER)-related pathways. We also found that sigma-1 receptor (SIGMAR1) knock out (KO) reversed NSP6-induced autophagosome abnormality and resisted SARS-CoV-2 infection, which responds to the fact that SIGMAR1 is likely to be used as a potential target for the treatment of SARS-CoV-2 infection. In summary, we have provided a preliminary explanation of the effects on autophagy of the SARS-CoV-2 NSP6 protein from the pre-autophagic and late stages, and also found that SIGMAR1 is likely to be used as a potential target for SARS-CoV-2 therapy to develop relevant drugs.
Importance:
We have provided a preliminary explanation of the effects on autophagy of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structure protein 6 from the pre-autophagic and late stages, and also found that sigma-1 receptor is likely to be used as a potential target for SARS-CoV-2 therapy to develop relevant drugs.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) NSP6 protein disrupts autophagy by inhibiting lysosome function. Sigma-1 receptor knockout reversed these effects and resisted SARS-CoV-2 infection, suggesting it as a therapeutic target.
Area of Science:
- Virology
- Cellular Biology
- Immunology
Background:
- Autophagy is a cellular process involved in pathogen defense and replication.
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non-structure protein 6 (NSP6) is implicated in modulating autophagy.
- The precise mechanisms by which SARS-CoV-2 NSP6 affects autophagy and viral replication remain unclear.
Purpose of the Study:
- To investigate the impact of SARS-CoV-2 NSP6 on autophagosome formation and function.
- To elucidate the role of sigma-1 receptor (SIGMAR1) in SARS-CoV-2 infection and autophagy modulation.
- To identify potential therapeutic targets for SARS-CoV-2 infection.
Main Methods:
- Investigated the effect of NSP6 from wild-type and Delta SARS-CoV-2 variants on autophagosome size.
- Examined the localization of SARS-CoV-2 NSP6 and its interaction with lysosomes.
- Assessed the impact of SIGMAR1 knockout (KO) on SARS-CoV-2 infection and autophagy.
- Analyzed endoplasmic reticulum (ER)-related pathways involved in NSP6-mediated autophagy inhibition.
Main Results:
- SARS-CoV-2 NSP6 reduced autophagosome size in wild-type and Delta variants.
- NSP6 localized to lysosomes, inhibiting autophagosome-lysosome fusion and blocking autophagy flux.
- SIGMAR1 KO reversed NSP6-induced autophagosome abnormalities and conferred resistance to SARS-CoV-2 infection.
- NSP6-induced autophagy inhibition may involve ER-related pathways.
Conclusions:
- SARS-CoV-2 NSP6 impairs autophagy by disrupting autophagosome-lysosome fusion, potentially via ER-related mechanisms.
- SIGMAR1 plays a critical role in SARS-CoV-2 pathogenesis and autophagy modulation.
- SIGMAR1 represents a promising therapeutic target for developing novel anti-SARS-CoV-2 drugs.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Regulation of Nuclear Protein Sorting
Leaky Scanning
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Viruses of Archaea

